Osteonecrosis of the Jaw during Lenvatinib Therapy: A Case Report Based on Surgical Management

Osteonecrosis of the Jaw during Lenvatinib Therapy: A Case Report Based on Surgical Management

Lenvatinib is a molecular targeted drug used in the treatment of patients with unresectable thyroid cancer. We present a case of medication-related osteonecrosis of the jaw (MRONJ), which occurred in a patient receiving lenvatinib therapy and which was treated by surgical management. The objectives...

Full description

Bibliographic Details
Main Authors: Gen Udagawa, Toshihiro Okamoto, Nobuyuki Kaibuchi, Noriko Sangu, Chie Kagawa, Tomohiro Ando
Format: Article
Language:English
Published: Society of Tokyo Women's Medical University 2019-11-01
Series:Tokyo Women's Medical University Journal
Subjects:
mronj
lenvatinib
antiangiogenic drug
drug holiday
Online Access:https://www.jstage.jst.go.jp/article/twmuj/3/0/3_2019002/_pdf/-char/en

Similar Items

Similar Items